Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 16;19(2):6.
doi: 10.1007/s11306-022-01968-7.

Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis

Affiliations

Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis

Rong Zhang et al. Metabolomics. .

Abstract

Introduction: Lipid metabolism participates in various biological processes such as proliferation, apoptosis, migration, invasion, and maintenance of membrane homeostasis of prostate tumor cells. Bufadienolides, the active ingredients of Chansu, show a robust anti-proliferative effect against prostate cancer cells in vitro, but whether bufadienolides could regulate the lipid metabolism in prostate cancer has not been evaluated.

Objectives: Our study explored the regulatory effects of bufadienolides on lipid metabolism in human prostate carcinoma cells (PC-3).

Methods: Untargeted lipidomics and transcriptomics were combined to study the effect of different bufadienolides interventions on lipid and gene changes of PC-3 cells. The key genes related to lipid metabolism and prostate cancer development were verified by qPCR and western blotting.

Results: Lipidomic analysis showed that the active bufadienolides significantly downregulated the content of long-chain lipids of PC-3 cells. Based on transcriptomic and qPCR analyses, many genes related to lipid metabolism were significantly regulated by active bufadienolides, such as ELOVL6, CYP2E1, GAL3ST1, CERS1, PLA2G10, PLD1, SPTLC3, and GPX2. Bioinformatics analysis of the Cancer Genome Atlas database and literature retrieval showed that elongation of very long-chain fatty acids protein 6 (ELOVL6) and phospholipase D1 (PLD1) might be important regulatory genes. Western blot analysis revealed that active bufadienolides could downregulate PLD1 protein levels which might promote anti-prostate cancer effect.

Conclusions: All these findings support that bufadienolides might induce lipid metabolic remodeling by regulating long-chain lipids synthesis and phospholipid hydrolysis to achieve an anti-prostate cancer effect, and PLD1 would probably be the key protein.

Keywords: Bufadienolides; ELOVL6; Lipidomics; PLD1; Prostate cancer; Transcriptomics.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016). Prostate cancer. The Lancet, 387(10013), 70–82. https://doi.org/10.1016/s0140-6736(14)61947-4 - DOI
    1. Berger, A. C., Korkut, A., Kanchi, R. S., Hegde, A. M., Lenoir, W., Liu, W., Liu, Y., Fan, H., Shen, H., Ravikumar, V., Rao, A., Schultz, A., Li, X., Sumazin, P., Williams, C., Mestdagh, P., Gunaratne, P. H., Yau, C., Bowlby, R., et al. (2018). A Comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell, 33(4), 690–705. https://doi.org/10.1016/j.ccell.2018.03.014 - DOI - PubMed - PMC
    1. Bowling, F. Z., Salazar, C. M., Bell, J. A., Huq, T. S., Frohman, M. A., & Airola, M. V. (2020). Crystal structure of human PLD1 provides insight into activation by PI(4,5)P2 and RhoA. Nature Chemical Biology, 16(4), 400–407. https://doi.org/10.1038/s41589-020-0499-8 - DOI - PubMed - PMC
    1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492 - DOI - PubMed
    1. Brigelius-Flohe, R., & Flohe, L. (2020). Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxidants & Redox Signaling, 33(7), 498–516. https://doi.org/10.1089/ars.2019.7905 - DOI

Publication types

LinkOut - more resources